Once-promising Genital Herpes Vaccine Fails in a Large Clinical Trial

by Dr. Trupti Shirole on  January 5, 2012 at 3:11 PM Women Health News
RSS Email Print This Page Comment
Font : A-A+

A once-promising genital herpes vaccine has failed in a large clinical trial, reported researchers. Researchers found that the vaccine efficacy was only 20%.
 Once-promising Genital Herpes Vaccine Fails in a Large Clinical Trial
Once-promising Genital Herpes Vaccine Fails in a Large Clinical Trial

About 8,300 uninfected women, aged 18-30 years, were part of this new study. Researchers found that the experimental genital herpes shot was only mildly effective against herpes simplex virus type 1 (HSV-1), which commonly causes cold sores and sometimes genital herpes; and not at all effective against herpes simplex virus 2 (HSV-2), the most common cause of genital herpes.

Study co-author Dr. Peter Leone said, "We will need to take a 'different type of vaccine approach' in order to find something that works against both viruses."

The study is published in the New England Journal of Medicine.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Cold Sores Shingles Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Top Ten Trivial Sex Facts Top Ten Sex Tips for Men Sex Numbers Placebo Effects: Rare Insights Genital Herpes 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive